載入...
Eye Movement Impairment Recovery in a Gaucher Patient Treated with Miglustat
In Gaucher Disease (GD) the enzyme (imiglucerase) replacement therapy (ERT) is not able to stop the progression of the neurological involvement, while the substrate reduction therapy (SRT), performed by N-Butyldeoxynojirimycin (miglustat), is an alternative that should be evaluated. Two sisters, pre...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Limited
2010-01-01
|
| 叢編: | Neurology Research International |
| 在線閱讀: | http://dx.doi.org/10.1155/2010/358534 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|